OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 153 filers reported holding OCULAR THERAPEUTIX INC in Q1 2021. The put-call ratio across all filers is 0.82 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $979,000 | -29.5% | 97,915 | 0.0% | 0.03% | -32.5% |
| Q2 2021 | $1,388,000 | -13.6% | 97,915 | 0.0% | 0.04% | -21.6% |
| Q1 2021 | $1,607,000 | -20.6% | 97,915 | +0.2% | 0.05% | -26.1% |
| Q4 2020 | $2,023,000 | +171.5% | 97,740 | -0.2% | 0.07% | +137.9% |
| Q3 2020 | $745,000 | -12.6% | 97,940 | -4.2% | 0.03% | -31.0% |
| Q2 2020 | $852,000 | +68.4% | 102,228 | 0.0% | 0.04% | +27.3% |
| Q1 2020 | $506,000 | +19.6% | 102,228 | -4.5% | 0.03% | +32.0% |
| Q4 2019 | $423,000 | – | 107,101 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 5,618,861 | $116,310,000 | 100.00% |
| Opaleye Management Inc. | 6,510,000 | $134,758,000 | 17.60% |
| DELTEC ASSET MANAGEMENT LLC | 2,168,573 | $44,889,000 | 6.87% |
| Versant Venture Management, LLC | 1,465,384 | $30,333,000 | 3.15% |
| GREAT POINT PARTNERS LLC | 856,162 | $17,723,000 | 2.88% |
| Affinity Asset Advisors, LLC | 220,000 | $4,554,000 | 2.41% |
| Altium Capital Management LP | 303,174 | $6,276,000 | 2.34% |
| Endurant Capital Management LP | 290,465 | $6,013,000 | 2.17% |
| MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 50,396 | $1,043,000 | 1.17% |
| Lisanti Capital Growth, LLC | 366,040 | $7,577,000 | 1.05% |